Zhongxi Sunve

Zhongxi Sunve is a prominent Chinese pharmaceutical company and a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. The company was formed through the strategic merger of two historical entities, Shanghai Zhongxi Pharmaceutical and Shanghai Sunve Pharmaceutical, combining their expertise in chemical drug production. It specializes in the research, development, and large-scale manufacturing of chemical raw materials (APIs) and finished dosage forms. Zhongxi Sunve maintains a strong market presence in several therapeutic areas, including psychiatry, neurology, and rheumatology. Notably, the company is one of the world's largest producers of hydroxychloroquine and chloroquine, which are critical for treating autoimmune diseases and malaria. Their portfolio includes a wide range of branded generics and innovative chemical drugs serving both domestic and international markets.